Transamerica Financial Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177K | Buy |
4,621
+1,019
| +28% | +$39.1K | 0.02% | 232 |
|
|
2025
Q1 | $140K | Buy |
3,602
+1,843
| +105% | +$71.6K | 0.01% | 244 |
|
|
2024
Q4 | $60K | Sell |
1,759
-1,735
| -50% | -$59.2K | 0.01% | 302 |
|
|
2024
Q3 | $143K | Buy |
3,494
+3,274
| +1,488% | +$134K | 0.01% | 248 |
|
|
2024
Q2 | $9K | Hold |
220
| – | – | ﹤0.01% | 316 |
|
|
2024
Q1 | $10K | Buy |
220
+219
| +21,900% | +$9.96K | ﹤0.01% | 344 |
|
|
2023
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 475 |
|
|
2023
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 503 |
|
|
2023
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 474 |
|
|
2023
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 461 |
|
|
2022
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 515 |
|
|
2022
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 486 |
|
|
2022
Q2 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 496 |
|
|
2016
Q2 | – | Sell |
-798
| Closed | -$41K | – | 520 |
|
|
2016
Q1 | $41K | Sell |
798
-723
| -48% | -$37.1K | ﹤0.01% | 388 |
|
|
2015
Q4 | $77K | Hold |
1,521
| – | – | 0.01% | 362 |
|
|
2015
Q3 | $74K | Sell |
1,521
-5,569
| -79% | -$271K | 0.01% | 345 |
|
|
2015
Q2 | $370K | Sell |
7,090
-371
| -5% | -$19.4K | 0.03% | 260 |
|
|
2015
Q1 | $431K | Buy |
7,461
+258
| +4% | +$14.9K | 0.03% | 245 |
|
|
2014
Q4 | $385K | Buy |
7,203
+2,245
| +45% | +$120K | 0.03% | 224 |
|
|
2014
Q3 | $285K | Buy |
4,958
+733
| +17% | +$42.1K | 0.03% | 227 |
|
|
2014
Q2 | $283K | Buy |
4,225
+100
| +2% | +$6.7K | 0.02% | 244 |
|
|
2014
Q1 | $276K | Buy |
+4,125
| New | +$276K | 0.03% | 221 |
|